SCHEMBL13478299

SCHEMBL13478299

O=C(N/N=C\c1cc(Br)ccc1O)N/N=C/c1cc(Br)ccc1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 13/20 0.77
KDM4E B2RXH2 12/20 0.77
GAA P10253 1/20 0.77
MAPT P10636 8/20 0.74
MEN1 O00255 8/20 0.74
POLB P06746 2/20 0.73
HTT P42858 9/20 0.66
LMNA P02545 6/20 0.66
RAB9A P51151 5/20 0.66
L3MBTL1 Q9Y468 3/20 0.66
NPC1 O15118 3/20 0.66
MITF O75030 3/20 0.66
ASF1A Q9Y294 2/20 0.66
TDP1 Q9NUW8 2/20 0.66
SMN1; SMN2 Q16637 4/20 0.63
PIK3CG P48736 1/20 0.63
PGR P06401 1/20 0.63
AR P10275 1/20 0.63
ALOX12 P18054 1/20 0.63
GPR174 Q9BXC1 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17438105 1.00 KMT2A (0.77) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL14535582 0.91 KMT2A (0.70) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL30310017 0.87 KMT2A (1.00) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL31393968 0.87 KMT2A (0.74) KMT2AKDM4EGAAMAPTMEN1
Hydrochloric Acid SCHEMBL6641972 0.86 KMT2A (0.97) KMT2AKDM4EGAAMAPTMEN1
Hydrochloric Acid SCHEMBL6641969 0.86 KMT2A (0.97) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL26974362 0.84 PGR (0.76) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL14195172 0.84 KMT2A (0.78) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL30495458 0.84 KMT2A (0.69) KMT2AKDM4EGAAMAPTMEN1
SCHEMBL9457623 0.83 KMT2A (0.68) KMT2AKDM4EGAAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8569356-B2 Cyclin dependent kinase inhibitors UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2013-10-29 US disclosed
US-8569356-B2 Cyclin dependent kinase inhibitors UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2013-10-29 US disclosed
US-20100035940-A1 Cyclin Dependent Kinase Inhibitors UNIVERSITY OF FLORDIA RESEARCH FOUNDATION (US) 2010-02-11 US disclosed
US-20100035940-A1 Cyclin Dependent Kinase Inhibitors UNIVERSITY OF FLORDIA RESEARCH FOUNDATION (US) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035940-A1 Cyclin Dependent Kinase Inhibitors CCNI, CCNK, CDK1 KMT2A 1153/4885KDM4E 1029/4885GAA 2597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.